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Abstract
Objective: Beta-trace protein (β-TP) has been analysed in human
cerebrospinal fluid (CSF) and other body fluids. Beta-trace protein is a
Olaf Michel
1
StephanBamborschke
2
very sensitive and specific clinical marker and can confirm reliably the
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3 Design: Perilymph specimens from the scala vestibuli (n=10) and from
thelateralsemicircularcanal(n=4)weretakenfrompatientsundergoing
stapedotomy or surgery for acoustic neuroma. During post-mortem ex-
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aminations perilymph specimens from the scala vestibuli (n=70), the
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Results: Specimens from live surgery showed a mean concentration of
51.5 ± 48.9 mg/l β-TP in scala vestibuli perilymph. Specimens from 2 University of Cologne,
Department of Neurology,
Cologne, Germany post-mortem examinations revealed a mean concentration of 49.1 ±
17.7 mg/l in CSF, 71.9 ± 29.3 mg/l in perilymph and 68.0 ± 21.7 mg/l
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in endolymph. There was no evidence of a circadian alteration of β-TP
in CSF or inner ear fluids.
Otorhinolaryngology,
Tromsoe, Norway Conclusions: Our results demonstrated clearly that β-TP is contained
in human perilymph and endolymph. This is the first published data
that point out the aptitude of the β-TP-test in verifying traces of
perilymph, a valuable diagnostic tool for the existence of perilymphatic
leaks.
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Zusammenfassung
Ziel:Beta-traceProtein(β-TP)wurdeindermenschlichenHirnflüssigkeit
(Liquor) und in anderen Körperflüssigkeiten nachgewiesen. Beta-trace
Protein ist ein sehr sensitiver und spezifischer klinischer Marker und
kann die Anwesenheit von Liquor cerebrospinalis in Patienten mit dem
Verdacht auf ein Liquorleck sicher nachweisen.
Methodik: Perilymph-Probenfrom aus der Scala vestibuli (n=10) und
vom lateralen Bogengang (n=4) wurden Patienten abgenommen, die
stapedotomiert oder wegen eines Akustikusneurinoms labyrinthekto-
miertwurden.AuchwurdenpostmortemhumanePerilymph-Probenfrom
aus der Scala vestibuli (n=70), der Scala tympani (n=11), Endolymphe
(n=21) und Liquorproben (n=17) entnommen. Alle Proben wurden mit
einereindimensionalenImmunoelektrophoreseundeinempolyclonalen,
monospezifischen Antikörper untersucht.
Ergebnisse:DieProben,diewährendderchirurgischenEingriffegewon-
nen wurden, wiesen eine mittlere Konzentration von 51,5 ± 48,9 mg/l
β-TP in der Perilymphe der Scala vestibuli auf. Proben, die post mortem
gewonnenwurden,wieseneinemittlereKonzentrationvon49,1±17,7
mg/l im Liquor, 71,9 ± 29,3 mg/l in der Perilymphe und 68,0 ± 21,7
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mus wurde weder im Liquor noch in der Perilymphe gefunden.
Schlussfolgerung:. Unsere Ergebnisse weisen nach, dass β-TP ohne
Ausnahme in der menschlichen Perilymphe und Endolymphe in hoher
Konzentration vorkommt. Dies sind die ersten veröffentlichten Daten,
diezeigen,dassderβ-TP-Testgeeignetist,auchSpurenvonPerilymphe
nachzuweisen. Damit steht erstmals ein klinischer Test zum sicheren
Nachweis von Perilymphfisteln zur Verfügung.
Schlüsselwörter: Beta-traceProtein,NachweisinPerilymphe,Nachweis
von Perilymphfisteln
Introduction
The incidence of perilymphatic fistula has been subject
to controversial discussions since they were first de-
scribed by Simmons [1]. The controversy arose due to
difficulties in diagnosing a perilymph fistula at tympano-
tomy. Unless there is profuse gushing of fluid, there is no
reliable, objective, intraoperative indicator of a
perilymphaticfistula[2],[3].Thesearchofspecificprotein
markers [4], [5] or the intravenousapplicationof fluores-
cein[6]hassofarnotbeensuccessful.Alsoβ2-transferrin
was reported to be unique in human perilymph [7], but
in a study of 22 patients more than half of them had
knownperilymphleaksβ2-transferrinwasfalselynegative
[8].
Since Felgenhauer [9] demonstrated beta-trace protein
(β-TP) to be after albumin the second most abundant
proteininhumancerebrospinalfluid(CSF)ithasbecome
a reliable marker for CSF leaks.
β-TP is completely different to β2-transferrin. With a mo-
lecular mass of 23.500 Dalton β-TP is identical to gluta-
thion-independent prostaglandin D synthase [10], which
seems to play an important role in regulating the sleep
and waking state [11]. So far, the highest concentrations
of β-TP were found in CSF and seminal fluid [12]. In ser-
um, the level of β-TP is below the detection limit (< 5
mg/l)ofrocketimmunoelectrophoresis.Onlyparticipants
with severe renal filtration barrier pathology would show
a detectable concentration of β-TP.
Withthemoresensitiveimmunofluorometricassay,which
is based on an enzymatic amplified time-resolved fluoro-
metry, the mean levels of β-TP were 0.3 mg/L in human
serum and 17 mg/L in human CSF and the detection
limit was 5 mg/L [13]. β-TP has the highest CSF/serum
ratio of all CSF specific proteins.
β-TP was found in aqueous humor, sperm and urine, too
[14].β-TPwasdetectedinhomogenateoftheratcochlea
[15]andinthelateralwallofthecochleaoftheMongolian
gerbil [16].
Based upon our experience with β-TP in the diagnosis in
CSF-leaks, the purpose of this study was to investigate
whether β-TP occurs in human inner ear fluids and if
positive, in which concentrations compared to CSF.
Subjects and methods
To clarify the occurrence of β-TP we conducted analysis
of perilymphatic fluid obtained from post-mortem exam-
inations and from inner ear surgery. In post-mortem ex-
aminations 81 perilymph, 21 endolymph specimens and
17 CSF specimens were collected.
14perilymphsamplesweresampledfrompatientsunder-
goingstapedotomyorlabyrinthectomyattheDepartment
of Otorhinolaryngology, University of Cologne. The
perilymphsamplesweretakenfromthelateralsemicircu-
lar canal (n=4) or from the oval window (n=10). Also
pooled CSF taken by lumbar puncture from 125 patients
with non-inflammatory diseases of the CNS was studied.
35 serum samples were collected from patients without
renaldisease.Subjectswitharenalinsufficiencyoracute
glomerulonephritis were not enrolled in this study.
Technique of sampling in post-mortem
examination
After partial mastoidectomy, removal of the posterior ear
canalandthetympanicmembraneincludingmalleusand
incus,thestapeswasexposedandthefootplatecarefully
removed.Samplesofperilymphweretakenfromthescala
vestibuli with precision capillary bores (Wiretrol 1-5 μl,
Drummond
®,Broomall,USA-Pennsylvania19008)under
microscopic view (Figure 1). To prevent contamination
with CSF, the samples were taken without active aspira-
tion only by the capillary power. The volume was limited
toaminimumof4μlandamaximumof5μl.Thecapillary
bores were placed near the upper edge of the vestibular
window, the membranous labyrinth was initially not
touched. After the sampling of a second and third
perilymph specimen of 5 μl, the utricle was punctured
and endolymph was obtained. If feasible, a second en-
dolymph specimen of 5 μl was taken. CSF specimens
were obtained from the third ventricle. The period
betweendeathandautopsyaswellasthecauseofdeath
were documented.
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Michel et al.: β-trace protein (prostaglandin ...Figure 1: Precision capillary bore (1-5 µl), placed at the edge
of the oval window under microscopic view (Magn.: 12 x), FN:
facial nerve, TN: tympanic nerve, OW: oval window
Techniqueofsamplingatstapessurgery
14 perilymph samples were obtained from patients un-
dergoingstapedotomyorlabyrinthectomy.Theperilymph
samples were taken from the oval window or from the
lateral semicircular canal using sterilized precision bore.
The volume of the fluid specimen was restricted to a
maximum of 5 μl. Because of the high specificity of β-TP,
small blood contamination or small dilution with local
anesthetic could be ignored.
In addition to the post-mortem CSF samples, pooled CSF
taken by lumbar puncture from 125 patients with non-
inflammatorydiseasesoftheCNSwasstudied.35serum
samples were collected from patients without renal dis-
ease.
Rocket immunoelectrophoresis
Allspecimenswereinvestigatedbyarocketimmunoelec-
trophoresis using a monospecific, polyclonal antibody,
used in rabbits [9]. Investigation took place either imme-
diately or after storage of maximum 7 days at - 40°C.
The standard electroimmunoassay as described by
Laurrell [16] was performed using a gel composition of
1.5% Litex agarose (Litex, Denmark), 0.02 M barbital
buffer pH 8.6, 1% antiserum, 1% polyethylenglycol 6000
(Merck, Darmstadt, Germany) and an electrophoresis
buffer of 0.02 M barbital buffer, pH 8.6. Electrophoresis
was performed during 3 hours at 18° C at a constant
voltage of 250 V. Semiquantitative measurements were
performed using a standard row with serial dilution of
purified β-TP isolated from pooled human CSF (Figure 2)
as described by Felgenhauer et al. [9].
Figure 2: Rocket electrophoresis with standard row on the left
(1-5). Specimen from surgery (6 and 9-10): scala vestibuli
perilymph. Specimen from post-mortem examination (7-8):
scala vestibuli perilymph. Specimen from post-mortem
examination (11): endolymph.
Results
Byimmunoelectrophoresistheperilymph,endolymphand
CSF specimens from post-mortem examination precipit-
ated clearly (Figure 2). In correlation with the time of
death, there was no clear evidence for a circadian altera-
tion(Figure3).Upto117hourspostmortemasignificant
change of the β-TP concentration in CSF and inner ear
fluids was not observed in males or females (Figure 4A,
B, C ). The values ranged between 8.5 mg/l and 165
mg/l.
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fluids and time of death. Scatterplot of β-TP concentration in
human perilymph and endolymph vs. time post-mortem.
Maximum between 10:00 and 12:00 p.m.
As depicted in Figure 5A , the mean concentration of β-
TP was 49.1 ± 17.7 mg/l in CSF and 59.0 ± 25.8 mg/l
in perilymph (scala tympani). In the first drawn specimen
of scala vestibuli perilymph β-TP was found in a concen-
trationof71.9±29.3mg/l.Inthesecondspecimenfrom
the scala vestibuli 78.7 ± 30.4 mg/l and in the third
specimen86.4±23.1mg/lweredetected.Inendolymph,
samples the values were 68.0 ± 21.7 mg/l (first speci-
men) and 80.5 ± 10.6 mg/l (second specimen). The first
perilymph specimen from the labyrinthine vestibule
showed a lower concentration compared to the second
or third specimens, which originated from deeper parts
of the scala vestibuli. The β-TP concentration in the
secondendolymphspecimenswasalsohigherincompar-
ison with the values from the first specimens.
The samples obtained during inner ear surgery were all
positive for β-TP. The specimens revealed a β-TP-concen-
tration of 61.5 ± 57.8 mg/l in perilymph from the lateral
semicircular canal and 51.4 ± 48.9 mg/l in perilymph
from the scala vestibuli (Figure 5B ).
In pooled CSF taken by lumbar puncture from 125 pa-
tientswithnon-inflammatorydiseases,aβ-TP-concentra-
tion of 28.4 mg/l was determined. All serum samples
were negative for β-TP.
Figure 4: A: Scatterplot of time after death vs. β-TP
concentrations (all specimens);
B: Scatterplot of time after death vs. β-TP concentrations in
males;
C: Scatterplot of time after death vs. β-TP concentrations in
females.
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Michel et al.: β-trace protein (prostaglandin ...Figure 5: A: β-TP concentrations in CSF and different inner ear
compartments from post-mortem examinations. 1 = scala
tympani perilymph (59.0 ± 25.8; n=11); 2 = III. ventricle CSF
(49.1 ± 17.7; n=17); 3 = third scala vestibuli perilymph
specimen (86.6 ± 23.1; n=7); 4 = second scala vestibuli
perilymph specimen (78.7 ± 30.3; n=27); 5 = first scala
vestibuli perilymph specimen (71.9 ± 29.2; n=36); 6 = second
endolymph specimen (80.5 ± 10.6; n=2); 7 = first endolymph
specimen (68.0 ± 21.6; n=19);
B: β-TP concentrations in different inner ear compartments
from surgical procedures. 1 = perilymph from the lateral
semicircular canal (61.5 ± 57.7; n=4); 2 = scala vestibuli
perilymph from the oval window (51.4 ± 48.9; n=10)
Discussion
The issue of whether perilymphatic fistula is the cause
of hearing loss remains enigmatic unless a specific
markerexistsforreliableproof.Withβ-TP,suchaspecific
marker could exist.
In human CSF, the occurrence and the concentration of
β-TP have been investigated by several authors and were
re-evaluated in this study (Table 1). β-TP has become a
reliable indicator for CSF-leak with advantages over β2-
transferrin. Although it is detectable in perilymph [17],
β2-transferrin did not provide evidence to be a reliable
clinical marker for perilymph in the operative setting be-
cause of its little sensitivity with 29% positive results [8].
Thisispartlyduetothepropertyofthisproteinasabrain-
specific variant of transferrin that lacks neuraminic acid.
It canbe distinguishedfromserumtransferrinby electro-
phoretic procedures only.
Our study now makes obvious that β-TP is detectable in
inner ear fluids in even higher concentration compared
to CSF. Nevertheless, our results are the first to quantify
β-TP in inner ear fluids. Tachibana and coworkers [15]
describedprostaglandinDsynthase(PGD-S)activityinrat
innerearhomogenate.Withthismethoditisnotpossible
to distinct where predominantly PGD-S could be found in
the inner ear.
Theanalysisofourentirespecimenrevealedahighinter-
individual variation between 8.5 and 165 mg/l, which
cannotyetbeexplainedduetotheunknownphysiological
roleofβ-TP.Withtheupcomingnewnephelometryicassay
itwillbemorefeasableinthefuturetoanalyseβ-TPunder
variousconditions.Nevertheless,β-TPprovedtobeavery
stable protein. Until 117 hours after sampling, no signi-
ficant variation in the β-TP concentration in the diverse
sampleswasdetected.Thesensitivitywas100%inn=81
perilymphandn=21endolymphsamples.Theconcentra-
tion of β-TP showed no significant divergence comparing
both inner ear fluids.
We did not find clear evidence for a circadian alteration
oftheβ-TP-levelininnerearfluidsasitcouldbeassumed
from its role in the sleep/awake rhythm and as detected
inCSF[18].Thehighestconcentrationswerefoundwhen
death had occurred around midnight. But a high interin-
dividual variation and not excludable post-mortem
changeshinderedastatisticalproofforacircadianrhythm
in our series. Nevertheless, the high interindividual vari-
ation as observed cannot be.
By this clear confirmation for the occurrence of β-TP in
innerearfluidsandparticularlyinperilymph,assessment
for clinical use is feasible without circumstantial and bi-
asing handling, which has been described for the β2-
transferrin test [19].
Thisisthefirstpublisheddatathatpointouttheaptitude
of the β-TP-test in verifying traces of perilymph in the
middle ear, a valuable diagnostic tool for the existence
of perilymphatic leaks as we have already shown in two
cases of an vestibulocochlear disorder [20]. Nowadays,
an immediate intraoperative check for β-TP is possible
by laser-nephelometry, which takes only 20 minutes de-
tection time [21].
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